Outcomes of EUS-guided transluminal gallbladder drainage in patients without cholecystitis

Duncan J Flynn1, Zoe Memel1, Yasmin Hernandez-Barco2

  • 1Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Endoscopic Ultrasound
|October 22, 2021
PubMed

Insights

Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is a safe and effective treatment for noncholecystitis gallbladder disease in patients unfit for surgery. This minimally invasive approach shows infrequent complications and readmissions, similar to its use in acute cholecystitis.

Area of Science:

  • Gastroenterology
  • Endoscopic procedures
  • Gallbladder disease management

Background:

  • Cholecystectomy is standard for gallbladder disease, but many patients are poor surgical candidates.
  • Nonsurgical gallbladder drainage (GBD) includes percutaneous cholecystostomy and endoscopic ultrasound-guided transluminal GBD (EUS-GBD).
  • Outcomes for EUS-GBD in noncholecystitis (NC) gallbladder disease are not well-defined.

Purpose of the Study:

  • To define the outcomes of EUS-GBD for noncholecystitis (NC) gallbladder disease.
  • To evaluate the safety and efficacy of EUS-GBD in patients unsuitable for surgery.

Main Methods:

  • Retrospective review of 55 EUS-GBD cases from 2015-2020 at an academic hospital.
  • Included patients with acute cholecystitis, biliary colic, gallstone pancreatitis, and secondary prevention of gallstone disease.
  • Analyzed complications, mortality, and reintervention rates.

Main Results:

  • Fifteen of 55 EUS-GBD cases were for NC indications, including biliary colic and gallstone disease prevention.
  • No statistically significant difference in complications, mortality, or reintervention compared to acute cholecystitis cases.
  • The NC group had a 13.3% immediate complication rate, all managed medically.

Conclusions:

  • EUS-GBD is a safe and effective option for managing NC gallbladder disease in nonsurgical candidates.
  • Overall complications and readmissions were infrequent.
  • EUS-GBD complication rates for NC disease are comparable to those for acute cholecystitis.
Abstract